Biofrontera (BFRI) EBITDA Margin (2020 - 2025)
Biofrontera's (BFRI) quarterly EBITDA Margin came in at 26.66% in Q4 2025, up 4029.0% year-on-year from 0.65% in Q4 2024, and up 129.68% quarter-over-quarter from 89.84% in Q3 2025.
Biofrontera (BFRI) EBITDA Margin (2020 - 2025) Analysis & Trends
Biofrontera's EBITDA Margin history runs 6 years deep, the most recent figure standing at 26.66% for Q4 2025.
- On a quarterly basis, EBITDA Margin rose 4029.0% year-over-year to 26.66% in Q4 2025; TTM through Dec 2025 was 27.2%, a 1891.0% increase from a year earlier, with the FY2025 full-year figure at 27.21%, up 1890.0% from the prior year.
- EBITDA Margin grew to 26.66% in Q4 2025 per BFRI's latest filing, from 89.84% in the prior quarter.
- Across five years, EBITDA Margin topped out at 26.66% in Q4 2025 and bottomed at 371.6% in Q3 2021.
- The 5-year median for EBITDA Margin is 59.57% (2023), against an average of 74.05%.
- Across the five-year window, EBITDA Margin plunged 29952 bps in 2021 and surged 28740 bps in 2022, its largest moves.
- Year by year, EBITDA Margin stood at 12.78% in 2021, then plunged by 531 bps to 55.02% in 2022, then soared by 34 bps to 36.48% in 2023, then surged by 63 bps to 13.63% in 2024, then surged by 296 bps to 26.66% in 2025.
- Per Business Quant, the three latest BFRI EBITDA Margin figures stand at 26.66% (Q4 2025), 89.84% (Q3 2025), and 56.25% (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.37% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 36.83% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -38.02% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 41.69% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -2.27% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.74% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.23% |
| 10 | Biofrontera | 12.70 Mn | 6.29 Mn | 14.09 Mn | 26.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.66% |
| Sep 30, 2025 | -89.84% |
| Jun 30, 2025 | -56.25% |
| Mar 31, 2025 | -52.95% |
| Dec 31, 2024 | -13.63% |
| Sep 30, 2024 | -55.04% |
| Jun 30, 2024 | -64.69% |
| Mar 31, 2024 | -69.10% |
| Dec 31, 2023 | -36.48% |
| Sep 30, 2023 | -51.93% |
| Jun 30, 2023 | -148.75% |
| Mar 31, 2023 | -62.89% |
| Dec 31, 2022 | -55.02% |
| Sep 30, 2022 | -84.20% |
| Jun 30, 2022 | -139.38% |
| Mar 31, 2022 | -31.89% |
| Dec 31, 2021 | 12.78% |
| Sep 30, 2021 | -371.60% |
| Jun 30, 2021 | -62.97% |
| Mar 31, 2021 | -73.78% |